| Literature DB >> 27780931 |
Mu Li1, Chen-Yang Dai1, Yu-Ning Wang2, Tao Chen1, Long Wang1, Ping Yang3, Dong Xie1, Rui Mao1, Chang Chen1.
Abstract
BACKGROUND: Although marital status is an independent prognostic factor in many cancers, its prognostic impact on tracheal cancer has not yet been determined. The goal of this study was to examine the relationship between marital status and survival in patients with tracheal cancer.Entities:
Keywords: SEER; marital status; socio-economics; survival analysis; tracheal cancer
Mesh:
Year: 2016 PMID: 27780931 PMCID: PMC5363576 DOI: 10.18632/oncotarget.12809
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Baseline demographic and clinical characteristics of patients
| Total | Married | Unmarried | ||
|---|---|---|---|---|
| 600 (100) | 344 (57.33) | 256 (42.67) | ||
| < 0.001 | ||||
| Male | 332 (55.33) | 216 (62.79) | 116 (45.31) | |
| Female | 268 (44.67) | 128 (37.21) | 140 (54.69) | |
| 63.63 ± 14.53 | 63.65 ± 12.98 | 63.60 ± 12.98 | 0.963 | |
| Race | 0.005 | |||
| White | 474 (79.00) | 274 (79.65) | 200 (78.13) | |
| Black | 77 (12.83) | 34 (9.88) | 43 (16.80) | |
| Other | 49 (8.17) | 36 (10.47) | 14 (5.08) | |
| 0.211 | ||||
| Localized | 220 (36.67) | 134 (38.95) | 86 (33.59) | |
| Regional | 205 (34.17) | 110 (31.98) | 95 (37.11) | |
| Distant | 96 (16.00) | 50 (14.53) | 46 (17.97) | |
| Unknown | 79 (13.17) | 50 (14.53) | 29 (11.33) | |
| 0.368 | ||||
| Grade I (well differentiated) | 29 (4.83) | 14 (4.07) | 15 (5.86) | |
| Grade II (moderately differentiated) | 144 (24.00) | 78 (22.67) | 66 (25.78) | |
| Grade III(poorly differentiated) | 141 (23.50) | 82 (23.84) | 59 (23.05) | |
| Grade IV(undifferentiated) | 26 (4.33) | 19 (5.52) | 7 (2.73) | |
| Unknown | 260 (43.33) | 151 (43.90) | 109 (42.58) | |
| 0.609 | ||||
| Squamous cell carcinoma | 299 (49.83) | 171 (49.71) | 128 (50.00) | |
| Adenoid cystic carcinoma | 107 (17.83) | 64 (18.60) | 43 (16.80) | |
| Small cell carcinoma | 51 (8.50) | 25 (7.27) | 26 (10.16) | |
| Others | 143 (23.83) | 84 (24.42) | 59 (23.05) | |
| 0.729 | ||||
| Yes | 133 (22.17) | 78 (22.67) | 55 (21.48) | |
| No | 467 (77.83) | 266 (77.33) | 201 (78.52) | |
| 0.744 | ||||
| Total resection | 39 (6.50) | 25 (7.27) | 14 (5.47) | |
| Subtotal resection | 230 (38.33) | 134 (38.95) | 96 (37.50) | |
| No cancer directed surgery | 323 (53.83) | 180 (52.33) | 143 (55.86) | |
| Unknown | 8 (1.33) | 5 (1.45) | 3 (1.17) | |
| 0.657 | ||||
| Radiotherapy | 378 (63.00) | 222 (64.53) | 156 (60.94) | |
| No radiotherapy | 199 (33.17) | 109 (31.69) | 90 (35.16) | |
| Unknown | 23 (3.83) | 13 (3.78) | 10 (3.91) | |
| 0.806 | ||||
| Lower 50% | 327 (54.50) | 186 (54.07) | 141 (55.08) | |
| Upper 50% | 273 (45.50) | 158 (45.93) | 115 (44.92) | |
| 0.339 | ||||
| Lower 50% | 134 (22.33) | 72 (20.93) | 62 (24.22) | |
| Upper 50% | 466 (77.77) | 272 (79.07) | 194 (75.78) | |
| 0.890 | ||||
| Lower 50% | 309 (51.50) | 178 (51.74) | 131 (51.17) | |
| Upper 50% | 291 (48.50) | 166 (48.26) | 125 (48.83) | |
| 0.787 | ||||
| Lower 50% | 184 (30.67) | 107 (31.10) | 77 (30.08) | |
| Upper 50% | 416 (69.27) | 237 (68.90) | 179 (69.92) |
Data were presented as number (percentage) of patients.
Unmarried group included divorced cases, single (never married) cases, widowed cases and cases separated with spouse.
p values were from the statistical analysis between married and unmarried patients.
Low-grade malignant tumors were defined as carcinoids, adenoid cystic carcinomas and mucoepidermoid carcinomas.
Data generated from 2000 national census data. Lower 50% indicated the patients live in counties below median level of national statistics. Upper 50% indicated the patients live in counties above median level of national statistics.
SEER 1990–2010 (n = 600).
Figure 1Survival curves in patients with tracheal cancer according to marital status, married vs. unmarried
(A) Overall survival (OS): χ2 = 6.92, p = 0.009. (B) Tracheal cancer specific survival (TCSS): χ2 = 8.11, p = 0.004.
Univariate and multivariate analysis for overall survival (OS) in tracheal cancer patients
| Variables | 5-year OS | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| Log rank χ2 | HR | 95% CI | ||||
| 2.82 | 0.093 | |||||
| Female | 33.73% | Reference | ||||
| Male | 29.77% | 0.82 | 0.67–1.01 | 0.061 | ||
| 107.73 | < 0.001 | |||||
| < 65 | 49.21% | Reference | ||||
| ≥ 65 | 14.66% | 2.00 | 1.62–2.46 | < 0.001 | ||
| 8.88 | 0.012 | |||||
| White | 28.18% | Reference | ||||
| Black | 37.96% | 0.90 | 0.67–1.20 | 0.467 | ||
| Other | 53.92% | 0.90 | 0.60–1.34 | 0.600 | ||
| 133.81 | < 0.001 | |||||
| Squamous cell carcinoma | 18.45% | Reference | ||||
| Adenoid cystic carcinoma | 75.12% | 0.82 | 0.38–1.75 | 0.601 | ||
| Small cell carcinoma | 0.00% | 1.22 | 0.86–1.73 | 0.264 | ||
| Others | 36.98% | 0.66 | 0.50–0.86 | 0.002 | ||
| 109.38 | < 0.001 | |||||
| Yes | 72.88% | Reference | ||||
| No | 19.74% | 2.27 | 1.15–4.47 | 0.018 | ||
| 23.16 | < 0.001 | |||||
| Grade I (well differentiated) | 57.39% | Reference | ||||
| Grade II (moderately differentiated) | 33.26% | 1.27 | 0.71–2.27 | 0.416 | ||
| Grade III (poorly differentiated) | 16.74% | 1.73 | 0.97–3.11 | 0.065 | ||
| Grade IV (undifferentiated) | 17.31% | 1.59 | 0.77–3.26 | 0.209 | ||
| Unknown | 37.64% | 1.35 | 0.77–2.36 | 0.294 | ||
| 99.00 | < 0.001 | |||||
| Localized | 45.49% | Reference | ||||
| Regional | 31.24% | 1.65 | 1.29–2.10 | < 0.001 | ||
| Distant | 11.01% | 2.75 | 2.06–3.69 | < 0.001 | ||
| Unknown | 18.29% | 1.50 | 1.10–2.04 | 0.009 | ||
| 167.92 | < 0.001 | |||||
| Surgery-total resection | 61.09% | Reference | ||||
| Surgery-subtotal resection | 52.26% | 1.80 | 1.06–3.05 | 0.029 | ||
| No cancer directed surgery | 13.33% | 3.75 | 2.20–6.39 | < 0.001 | ||
| Unknown | 25.00% | 2.72 | 1.04–7.11 | 0.041 | ||
| 7.58 | 0.023 | |||||
| Radiotherapy | 33.39% | Reference | ||||
| No radiotherapy | 28.38% | 2.06 | 1.62–2.61 | < 0.001 | ||
| Unknown | 27.05% | 1.69 | 0.95–3.03 | 0.076 | ||
| 6.92 | 0.009 | |||||
| Unmarried | 25.64% | Reference | ||||
| Married | 35.89% | 0.78 | 0.64–0.95 | 0.015 | ||
| 0.74 | 0.389 | |||||
| Lower 50% | 32.01% | Reference | ||||
| Upper 50% | 30.89% | 0.87 | 0.65–1.16 | 0.332 | ||
| 0.66 | 0.417 | |||||
| Lower 50% | 30.38% | Reference | ||||
| Upper 50% | 31.94% | 1.21 | 0.92–1.58 | 0.166 | ||
| 1.19 | 0.275 | |||||
| Lower 50% | 30.80% | Reference | ||||
| Upper 50% | 32.24% | 0.90 | 0.70–1.17 | 0.445 | ||
| 3.57 | 0.059 | |||||
| Lower 50% | 26.40% | Reference | ||||
| Upper 50% | 33.77% | 0.85 | 0.66–1.10 | 0.206 | ||
SEER 1990–2010 (n = 600).
Univariate and multivariate analysis for tracheal cancer specific survival (TCSS) in tracheal cancer patients
| Variables | 5-year TCSS | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| Log rank χ2 | HR | 95% CI | ||||
| 2.45 | 0.118 | |||||
| Female | 55.69% | Reference | ||||
| Male | 50.38% | 0.83 | 0.63–1.08 | 0.161 | ||
| 23.16 | < 0.001 | |||||
| < 65 | 61.91% | Reference | ||||
| ≥ 65 | 41.27% | 1.44 | 1.10–1.89 | 0.008 | ||
| 7.62 | 0.022 | |||||
| White | 48.88% | Reference | ||||
| Black | 66.47% | 0.74 | 0.49–1.13 | 0.168 | ||
| Other | 67.87% | 1.11 | 0.66–1.86 | 0.696 | ||
| 88.86 | < 0.001 | |||||
| Squamous cell carcinoma | 40.85% | Reference | ||||
| Adenoid cystic carcinoma | 84.44% | 0.84 | 0.30–2.39 | 0.750 | ||
| Small cell carcinoma | 0.00% | 1.42 | 0.92–2.19 | 0.109 | ||
| Others | 60.25% | 0.67 | 0.46–0.97 | 0.034 | ||
| 53.23 | < 0.001 | |||||
| Yes | 83.17% | Reference | ||||
| No | 41.53% | 2.25 | 0.87–5.84 | 0.094 | ||
| 13.77 | 0.008 | |||||
| Grade I (well differentiated) | 78.24% | Reference | ||||
| Grade II (moderately differentiated) | 58.88% | 1.12 | 0.52–2.43 | 0.773 | ||
| Grade III (poorly differentiated) | 35.44% | 1.50 | 0.69–3.23 | 0.306 | ||
| Grade IV (undifferentiated) | 32.34% | 1.75 | 0.70–4.41 | 0.234 | ||
| Unknown | 56.89% | 1.47 | 0.70–3.08 | 0.305 | ||
| 116.12 | < 0.001 | |||||
| Localized | 74.72% | Reference | ||||
| Regional | 44.97% | 2.76 | 1.94–3.93 | < 0.001 | ||
| Distant | 21.50% | 4.80 | 3.23–7.14 | < 0.001 | ||
| Unknown | 46.50% | 2.20 | 1.41–3.43 | 0.001 | ||
| 94.28 | < 0.001 | |||||
| Surgery-total resection | 73.68% | Reference | ||||
| Surgery-subtotal resection | 71.17% | 1.69 | 0.88–3.27 | 0.117 | ||
| No cancer directed surgery | 33.50% | 3.27 | 1.69–6.34 | < 0.001 | ||
| Unknown | 37.50% | 3.49 | 1.15–10.59 | 0.028 | ||
| 1.45 | 0.484 | |||||
| Radiotherapy | 53.36% | Reference | ||||
| No radiotherapy | 52.24% | 1.80 | 1.31–2.47 | < 0.001 | ||
| Unknown | 56.79% | 1.08 | 0.47–2.49 | 0.854 | ||
| 8.11 | 0.004 | |||||
| Unmarried | 44.58% | Reference | ||||
| Married | 58.75% | 0.70 | 0.54–0.91 | 0.008 | ||
| 0.96 | 0.327 | |||||
| Lower 50% | 54.80% | Reference | ||||
| Upper 50% | 50.43% | 1.08 | 0.74–1.59 | 0.679 | ||
| 5.10 | 0.023 | |||||
| Lower 50% | 42.86% | Reference | ||||
| Upper 50% | 55.81% | 0.97 | 0.69–1.36 | 0.858 | ||
| 0.03 | 0.863 | |||||
| Lower 50% | 53.26% | Reference | ||||
| Upper 50% | 52.19% | 1.25 | 0.88–1.76 | 0.210 | ||
| 2.50 | 0.114 | |||||
| Lower 50% | 46.20% | Reference | ||||
| Upper 50% | 55.62% | 1.02 | 0.72–1.43 | 0.933 | ||
SEER 1990–2010 (n = 600).
Figure 2Survival curves in NLGMT and LGMT subgroup patients, married vs. unmarried
(A) NLGMT subgroup, tracheal cancer specific survival (TCSS): χ2 = 10.60, p = 0.001. (B) LGMT subgroup, tracheal cancer specific survival (TCSS): χ2 = 0.02, p = 0.876. * No “median survival” calculated in LGMT subgroup because event happened in less than 50% patients at the end of follow-up.